<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kimia Biosciences Ltd has informed BSE that it does not meet the criteria to be classified as a 'Large Corporate' under the SEBI circular dated August 10, 2021, as assessed on March 31, 2025. Because of this, the additional disclosures required from Large Corporates regarding debt securities are not applicable to the company. The letter was signed by Managing Director & CEO Sameer Goel on May 16, 2025.
This is a routine regulatory compliance filing with no material impact on shareholders or the stock price. It simply confirms that the company is below the Large Corporate threshold and therefore does not need to make the extra debt-related disclosures that larger entities must file.